Pfizer, Inc. (PFE) Tops Q3 EPS by 2c; Boosts FY13 Outlook
Tweet Send to a Friend
Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.58, $0.02 better than the analyst estimate of $0.56 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
